Chinese vaping industry leaders RELX and SMOORE have embarked on various programs in line with their commitment to cross-disciplinary fundamental research on atomization mechanism to explore the long-term health effects of vaping.
China’s leading vape brand, RELX, initiated China’s first clinical research on vaping safety. It studies the acute effects of traditional cigarettes and e-cigarettes on the human respiratory system and cardiovascular system. In February 2022, this clinical research was registered on the China Clinical Trial Registry (ChiCTR), a primary registry in the World Health Organization (WHO) Registry Network.
In early March 2021, RELX conducted another clinical research on the metabolism and kinetics of nicotine.
In both clinical researches, RELX adopted vaping devices made by FEELM, the flagship atomization tech brand belonging to SMOORE, a global leader in atomization technology. FEELM has been in strategic partnership with RELX since 2018 as an atomization solution provider.
In September 2021, RELX and SMOORE took the lead in drafting two industry standards – the General Technical Specifications for Electronic Atomization Devices and Safety Technical Specifications for e-Liquids – led by the Electronic Cigarette Industry Committee of the China Electronic Chamber of Commerce (ECCC).
In October 2020, a research program on vaping harm reduction jointly conducted by SMOORE and Tongji University was approved by the National Natural Science Foundation of China. Over the next few years, SMOORE and Tongji University will continue to conduct a series of researches on the health effects of vaping.
As the industry's quality benchmark, FEELM is in compliance with its in-house SMOORE 3.0 safety standards. Based on the risk assessment guidance of the US Environmental Protection Agency (EPA), SMOORE 3.0 covers all of the PMTA tests, including material safety and vapor safety. It also covers all the HPHCs (harmful and potentially harmful constituents) listed by the US Food and Drug Administration (FDA). In addition, FEELM has developed a comprehensive safety assessment system, including PMTA non-clinical testing and PMTA health risk assessment.
Meanwhile, FEELM launched the world’s thinnest ceramic coil vape pod solution – FEELM Air – in London on January 18, 2022. Compared with the last generation, FEELM Air boasts an overall harm reduction performance improvement of 80%.